Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GalSeq was an Italian private genomics services company focused on next-generation sequencing and bioinformatics for the research community. The company offered standard and customized NGS services, including library preparation, sequencing, and downstream bioinformatic analysis. GalSeq appears to have operated primarily as a service provider rather than a therapeutic drug developer, and available evidence indicates work on custom panels such as a gene panel for acute myeloid leukemia research developed with a hospital hematology group. Multiple business-directory sources now list the company as inactive or in liquidation, suggesting that it is no longer operating as an active independent business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GalSeq.